Stay updated with breaking news from Chii min hwu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sodium-glucose co-transporter 2 inhibitor use was associated with significantly lower risks for diabetic retinopathy compared with the use of dipeptidyl peptidase-4 inhibitors, sulfonylureas, and pioglitazone. Sodium-glucose cotransporter 2 (SGLT2) inhibitors may reduce the risk of severe diabetic retinopathy threatening patients’ vision. ....
SGLT2 Inhibitors May Offer Better Protection Against Diabetic Retinopathy empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.
Sodium-glucose co-transporter 2 inhibitor use was associated with significantly lower risks for diabetic retinopathy compared with the use of dipeptidyl peptidase-4 inhibitors, sulfonylureas, and pioglitazone. Sodium-glucose cotransporter 2 (SGLT2) inhibitors may reduce the risk of severe diabetic retinopathy threatening patients’ vision. ....
SGLT2 inhibitors show a reduced risk of retinopathy compared with DPP-4 inhibitors, pioglitazone, and sulfonylureas among patients with type 2 diabetes. ....
Taiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in patients. ....